Today's Wall Street Journal has a (front page in the print edition) article that nicely summarizes some cases of a "Worrisome Ailment in Medicine: Misleading Journal Articles." It includes such cases as the controlled trial of Celebrex that included only six-month data (when the twelve-month data failed to show a benefit). As Jeffrey Drazen, editor of the New England Journal of Medicine put it, editors have "found themselves playing a game of hide-and-seek," including "experiences where authors tried to pitch it, where they were telling you the good news and not the bad."
(NB: the link above should work without requiring a subscription.)
The Finns are coming, the Finns are coming (to Health 2.0!) - By MATTHEW HOLT One of the great things that I’ve seen in a couple of decades of watching health tech has been the democratization of technology, and the a...
2 hours ago